Jonathan R. Brody, PhD | Authors

Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer

March 15, 2017

In this article, we review seminal articles that have evaluated the molecular architecture of pancreatic cancer. We compare the methods used and the molecular subtypes defined, and assess the predominant subgroups in order to better understand which therapies may improve patient outcomes.

Current Standards and Novel Treatment Options for Metastatic Pancreatic Adenocarcinoma

November 16, 2015

This article reviews the current treatment paradigms for metastatic disease, focusing on ways to ameliorate symptoms and lengthen survival. We then summarize recent advances in our understanding of the molecular and cellular aspects of pancreatic cancer.